Advancing scientific understanding and medicine by providing solutions for cell and gene therapy and biomedical research

Miltenyi Biotec is a global leader in innovating technologies and services for patient-specific cell and gene therapies, turning scientific discoveries into practical treatments for personalized medicine. Having pioneered a groundbreaking method of cell separation, Miltenyi Biotec continues to set industry standards today. With over 35 years of expertise, it supports customers in biomedical discoveries, translating them into clinical applications to enable access to new therapies for patients. Miltenyi Biotec focuses on providing integrated, advanced solutions to address complex challenges in the treatment of cancers, autoimmune diseases, and inherited disorders. Through its Miltenyi Bioindustry division, it provides expert guidance to therapy developers, helping them efficiently and cost-effectively navigate the path from process development to commercialization. Miltenyi Biotec is headquartered in Bergisch Gladbach and has a global team of 4,700 employees across 24 countries.

Our local team of technical, sales and application specialists support Life Science in Academia and Industry across the Nordic and Baltic countries. Don’t hesitate to get in touch with our Stockholm-based team:

Research sales

Ana Lukic

analu@miltenyi.com

Clinical sales

Jessica Gracias Lekander

jessicagr@miltenyi.com

Capital equipment

Olof Berggren

olofb@miltenyi.com